Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.
Jia Y, Han L, Ramage CL, Wang Z, Weng CC, Yang L, Colla S, Ma H, Zhang W, Andreeff M, Daver N, Jain N, Pemmaraju N, Bhalla K, Mustjoki S, Zhang P, Zheng G, Zhou D, Zhang Q, Konopleva M.
Jia Y, et al. Among authors: zhang p, zhang q, zhang w.
Haematologica. 2023 Oct 1;108(10):2626-2638. doi: 10.3324/haematol.2022.281915.
Haematologica. 2023.
PMID: 37078252
Free PMC article.